Published in J Cardiovasc Pharmacol on March 31, 1986
Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: experience in patients admitted to a general internal medicine department. Postgrad Med J (1999) 1.39
Resting, and rate-dependent depression of Vmax of guinea-pig ventricular action potentials by amiodarone and desethylamiodarone. Br J Pharmacol (1987) 0.93
Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes. Br J Pharmacol (1996) 0.87
Block of cardiac sodium channels by amiodarone studied by using Vmax of action potential in single ventricular myocytes. Br J Pharmacol (1991) 0.80
Amiodarone in long term prophylaxis. Drugs (1991) 0.79
Effects of long-term oral administration of amiodarone on the electromechanical performance of rabbit ventricular muscle. Br J Pharmacol (1992) 0.78
Dasatinib and Prednisolone Induction Therapy for a Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Dilated Cardiomyopathy Accompanied by Life-Threatening Ventricular Tachycardia. Case Rep Hematol (2017) 0.75
The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol (1970) 5.24
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med (1995) 3.56
Spred is a Sprouty-related suppressor of Ras signalling. Nature (2001) 2.87
A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol (1970) 2.78
Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet (1996) 2.77
Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med (1994) 2.68
Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol (1995) 2.31
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem (2001) 2.29
Noninvasive pulsed Doppler determination of cardiac output in neonates and children. J Pediatr (1982) 2.13
New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis (1980) 1.95
L-arginine-induced hypotension. Lancet (1990) 1.77
Abscisic Acid localization and metabolism in barley aleurone layers. Plant Physiol (1979) 1.71
Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation (1978) 1.68
Plasma propranolol concentration in patients with angina and acute myocardial infarction. Clin Exp Pharmacol Physiol (1976) 1.68
JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proc Natl Acad Sci U S A (1999) 1.65
Effects of intravenous verapamil on hemodynamics in patients with heart disease. Am Heart J (1977) 1.63
Effects of amiodarone on thyroid function in patients with ischaemic heart disease. Br Heart J (1975) 1.63
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation (2000) 1.63
Significant pulmonary valve incompetence following oversize balloon pulmonary valveplasty in small infants: A long-term follow-up study. Catheter Cardiovasc Interv (1999) 1.59
Cytologic findings in aspirated hydatid fluid. Acta Cytol (1989) 1.58
Amiodarone and thyroid function. Prog Cardiovasc Dis (1989) 1.55
Review of wheat improvement for waterlogging tolerance in Australia and India: the importance of anaerobiosis and element toxicities associated with different soils. Ann Bot (2008) 1.53
Comparative mechanisms of action of antiarrhythmic drugs. Am Heart J (1974) 1.52
Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. Am J Cardiol (1999) 1.49
Anti-tumor promoting action of phthalic acid mono-n-butyl ester cupric salt, a biomimetic superoxide dismutase. Carcinogenesis (1990) 1.49
Mechanisms of Igf2/H19 imprinting: DNA methylation, chromatin and long-distance gene regulation. J Biochem (2000) 1.48
Crystal structure of a repair enzyme of oxidatively damaged DNA, MutM (Fpg), from an extreme thermophile, Thermus thermophilus HB8. EMBO J (2000) 1.48
L-arginine-induced hypotension. Lancet (1991) 1.47
Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol (1990) 1.47
Verapamil: a review of its pharmacological properties and therapeutic use. Drugs (1978) 1.47
Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J Biol Chem (2001) 1.44
Crystal structure of Thermus thermophilus HB8 UvrB protein, a key enzyme of nucleotide excision repair. J Biochem (1999) 1.43
Balloon disruption of pulmonary artery band in a child with congenital heart disease. Pediatr Cardiol (1999) 1.43
Purification of the N-type calcium channel associated with syntaxin and synaptotagmin. A complex implicated in synaptic vesicle exocytosis. J Biol Chem (1994) 1.43
Non-Q-wave myocardial infarction-current status. J Assoc Physicians India (1988) 1.40
The origin of hypsarrhythmia and tonic spasms in West syndrome: evidence from a case of porencephaly and hydrocephalus with focal hypsarrhythmia. Brain Dev (1999) 1.40
Guidance with real-time CT fluoroscopy: early clinical experience. Radiology (1996) 1.40
Sex-related differences in drug metabolism. Drug Metab Rev (1974) 1.38
Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases. Proc Natl Acad Sci U S A (1994) 1.37
cDNA cloning of the hydroxysteroid sulfotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP-2 in rat livers. Biochem Biophys Res Commun (1990) 1.37
Studies on the mechanism of drug-induced microsomal enzyme activities. V. Phenobarbital stimulation of endogenous messenger RNA and polyuridylic acid-directed L-[14C]-phenylalanine incorporation. Mol Pharmacol (1966) 1.36
A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function. Cardiovasc Res (1972) 1.36
Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics (1977) 1.35
Effects of verapamil on infarct size following experimental coronary occlusion. Cardiovasc Res (1975) 1.32
Comparative genomic sequencing identifies novel tissue-specific enhancers and sequence elements for methylation-sensitive factors implicated in Igf2/H19 imprinting. Genome Res (2000) 1.30
Effect of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit atrial and ventricular muscle. Circ Res (1971) 1.29
Endothelin-mediated stimulation of DNA synthesis in vascular smooth muscle cells. Biochem Biophys Res Commun (1989) 1.26
Therapeutic implications of slow-channel blockade in cardiocirculatory disorders. Circulation (1980) 1.26
Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone. Am Heart J (1981) 1.25
Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro. Infect Immun (2000) 1.25
Noninvasive identification of a high risk subset of patients with acute inferior myocardial infarction. Am J Cardiol (1980) 1.24
Metabolism of drugs in old rats. II. Metabolism in vivo and effect of drugs in old rats. Jpn J Pharmacol (1968) 1.23
Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias. Pharmacol Rev (1978) 1.23
Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab (1981) 1.22
Effects of cardioselective beta adrenoceptor blockade on specific airways resistance in normal subjects and in patients with bronchial asthma. Clin Pharmacol Ther (1976) 1.22
Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations. Am Heart J (1985) 1.22
Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. J Am Coll Cardiol (1999) 1.21
Active site of mu-conotoxin GIIIA, a peptide blocker of muscle sodium channels. J Biol Chem (1991) 1.21
Failure of ST segment elevation to predict severity of acute myocardial infarction. Br Heart J (1976) 1.21
Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart : comparison with amiodarone. Circulation (1999) 1.20
Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics. J Am Coll Cardiol (1986) 1.20
The frequency and prognostic significance of electrocardiographic abnormalities in clinically normal individuals. Prog Cardiovasc Dis (1981) 1.19
Studies on pathogenic and non-pathogenic small free-living amoebae and the bearing of nuclear division on the classification of the order amoebida. Philos Trans R Soc Lond B Biol Sci (1970) 1.19
Limit on neutrinoless ββ decay of 136Xe from the first phase of KamLAND-Zen and comparison with the positive claim in 76Ge. Phys Rev Lett (2013) 1.18
Meningococcal meningitis presenting as acute cerebellar ataxia. Pediatrics (1973) 1.18
The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs. Circulation (1979) 1.17
Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett (1995) 1.17
Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT. Bone Marrow Transplant (2011) 1.17
Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer. Cardiovasc Res (1973) 1.17
Mechanism of rest and nocturnal angina: observations during continuous hemodynamic and electrocardiographic monitoring. Circulation (1979) 1.16
Thyroid hormone and activities of drug-metabolizing enzymes and electron transport systems of rat liver microsomes. Mol Pharmacol (1968) 1.16
Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy (2012) 1.16
Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci (1993) 1.16
Early effects of gibberellic acid on barley aleurone layers. Biochem Biophys Res Commun (1968) 1.15
Suppression of levels of phenobarbital-inducible rat liver cytochrome P-450 by pituitary hormone. J Biol Chem (1987) 1.15
Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol (1987) 1.14
Elevated levels of interleukin-8 and leukotriene B4 in pulmonary edema fluid of a patient with reexpansion pulmonary edema. Am J Respir Crit Care Med (1994) 1.13
Amiodarone: historical development and pharmacologic profile. Am Heart J (1983) 1.12
Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death. J Hypertens (1992) 1.12
Electrophysiologic effects of amiodarone: experimental and clinical observation relative to serum and tissue drug concentrations. Am Heart J (1984) 1.11
Local anaesthetic and anti-arrhythmic actions of alprenolol relative to its effect on intracellular potentials and other properties of isolated cardiac muscle. Br J Pharmacol (1970) 1.10
Failure of 1-oleoyl-2-acetylglycerol to mimic the cell-differentiating action of 12-O-tetradecanoylphorbol 13-acetate in HL-60 cells. J Biol Chem (1985) 1.10
Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J (1992) 1.10
Sinus node dysfunction in children, adolescents, and young adults. Pediatrics (1978) 1.10
Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. J Neurochem (1994) 1.10
Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J Neurosci (1995) 1.09
Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med (2000) 1.09
Dopamine receptor blocking activity of sulpiride in the central nervous system. Jpn J Pharmacol (1977) 1.07
A 1.2-megabase BAC/PAC contig spanning the 14q13 breakpoint of t(2; 14) in a mirror-image polydactyly patient. Genomics (1997) 1.06
Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. Circulation (1982) 1.05
Mismatch DNA recognition protein from an extremely thermophilic bacterium, Thermus thermophilus HB8. Nucleic Acids Res (1996) 1.05
Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs. J Vet Intern Med (2008) 1.05
Left ventricular ejection fraction determined by radionuclide ventriculography in early stages of first transmural myocardial infarction. Relation to short-term prognosis. Am J Cardiol (1980) 1.05
Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias. Drugs (1979) 1.05